Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Annals of Hematology|April 20, 2019
Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal originMotoko Yamaguchi, Ritsuro Suzuki, Kana Miyazaki, et al.
Cancer|April 9, 2026
Treatment and outcomes of pulmonary mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 186 patientsKazutaka Suzuki, Kana Miyazaki, Naoko Asano, et al.
Blood|June 26, 2020
Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphomaHyera Kim, Hyehyun Jeong, Motoko Yamaguchi, et al.
Haematologica|October 15, 2020
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II studyKana Miyazaki, Naoko Asano, Tomomi Yamada, et al.
Cancer Science|March 31, 2018
Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapyMotoko Yamaguchi, Ritsuro Suzuki, Seok Jin Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in JapanMotoko Yamaguchi, Ritsuro Suzuki, Masahiko Oguchi, et al.
Hematological Oncology|February 10, 2022
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphomaKana Miyazaki, Ritsuro Suzuki, Masahiko Oguchi, et al.
Eclinicalmedicine|February 19, 2025
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): long-term results of a multicentre, single-arm, phase 2 trialKazuyuki Shimada, Motoko Yamaguchi, Yachiyo Kuwatsuka, et al.
The Lancet. Oncology|March 15, 2020
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trialKazuyuki Shimada, Motoko Yamaguchi, Yoshiko Atsuta, et al.
Hematological Oncology|February 12, 2025
Treatments and Outcomes of Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational StudyYuma Nato, Kana Miyazaki, Dai Maruyama, et al.
Pageof 8